IceCure Medical's ProSense System Adopted by Shero Imaging in Missouri

Reuters
Feb 11
IceCure Medical's ProSense System Adopted by Shero Imaging in Missouri

IceCure Medical Ltd. announced that Shero Imaging in St. Louis, Missouri, has purchased and installed the ProSense® system, becoming the first clinic in the state to offer breast cancer cryoablation procedures with this technology. The ProSense® system recently received FDA marketing authorization for the treatment of low-risk breast cancer. Shero Imaging will provide the minimally invasive procedure under the direction of Dr. Tish Singer, the clinic's founder and board-certified breast radiologist.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief on February 11, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10